← Back to headlines
Liquidia Targets $1 Billion Net Revenue by 2027 Amid Rising YUTREPIA Sales
Liquidia Corporation aims to achieve at least $1 billion in net revenue by 2027, driven by a 44% sequential increase in Q1 net product sales for its drug YUTREPIA.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Singer Lionel Richie Hospitalized in ICU Following Concert Illness in St. Louis
1h ago
Croatia Launches Mosquito Control Campaign Amid West Nile Virus Outbreak
1h ago
Lionel Richie Hospitalized in ICU Following St. Louis Concert
4h ago
Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths
5h ago